Quantitative Mass Spectrometry Imaging Reveals Mutation Status-independent Lack of Imatinib in Liver Metastases of Gastrointestinal Stromal Tumors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantitative Mass Spectrometry Imaging Reveals Mutation Status-independent Lack of Imatinib in Liver Metastases of Gastrointestinal Stromal Tumors
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-23
DOI
10.1038/s41598-019-47089-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insights into the MALDI Process after Matrix Deposition by Sublimation Using 3D ToF-SIMS Imaging
- (2018) Sebastiaan Van Nuffel et al. ANALYTICAL CHEMISTRY
- Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2018) P G Casali et al. ANNALS OF ONCOLOGY
- Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review
- (2018) John G. Swales et al. INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
- Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging
- (2018) Meiko Nishimura et al. Oncotarget
- Advances and Challenges on Management of Gastrointestinal Stromal Tumors
- (2018) Lin Mei et al. Frontiers in Oncology
- Advanced MALDI mass spectrometry imaging in pharmaceutical research and drug development
- (2018) Sandra Schulz et al. CURRENT OPINION IN BIOTECHNOLOGY
- Metabolic origins of spatial organization in the tumor microenvironment
- (2017) Carlos Carmona-Fontaine et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
- (2017) César Serrano et al. Targeted Oncology
- Microenvironment Tumor Metabolic Interactions Highlighted by qMSI: Application to the Tryptophan-Kynurenine Pathway in Immuno-Oncology
- (2017) Rima Ait-Belkacem et al. SLAS Discovery
- Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imaging
- (2017) Yukari Tsubata et al. Scientific Reports
- Imaging mass spectrometry in drug development and toxicology
- (2016) Oskar Karlsson et al. ARCHIVES OF TOXICOLOGY
- Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study
- (2016) M.F.J. Seesing et al. EJSO
- Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer
- (2016) B. M. Gru ner et al. MOLECULAR CANCER THERAPEUTICS
- FDR-controlled metabolite annotation for high-resolution imaging mass spectrometry
- (2016) Andrew Palmer et al. NATURE METHODS
- Protein biomarkers on tissue as imaged via MALDI mass spectrometry: A systematic approach to study the limits of detection
- (2016) Stephanie M. W. Y. van de Ven et al. PROTEOMICS
- Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imaging
- (2016) Hiroaki Aikawa et al. Scientific Reports
- Molecular imaging of brain localization of liposomes in mice using MALDI mass spectrometry
- (2016) Annabelle Fülöp et al. Scientific Reports
- Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer
- (2016) Isabel Hinsenkamp et al. NEOPLASIA
- Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging
- (2016) Silvia Giordano et al. Scientific Reports
- 3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors
- (2016) S. Giordano et al. Scientific Reports
- Detailed study of imatinib metabolization using high-resolution mass spectrometry
- (2015) David Friedecký et al. JOURNAL OF CHROMATOGRAPHY A
- Label-Free in Situ Monitoring of Histone Deacetylase Drug Target Engagement by Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry Biotyping and Imaging
- (2014) Bogdan Munteanu et al. ANALYTICAL CHEMISTRY
- A critical evaluation of the current state-of-the-art in quantitative imaging mass spectrometry
- (2013) Shane R. Ellis et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- A Mimetic Tissue Model for the Quantification of Drug Distributions by MALDI Imaging Mass Spectrometry
- (2013) M. Reid Groseclose et al. ANALYTICAL CHEMISTRY
- CT-based response assessment of advanced gastrointestinal stromal tumor: Dual energy CT provides a more predictive imaging biomarker of clinical benefit than RECIST or Choi criteria
- (2013) M. Meyer et al. EUROPEAN JOURNAL OF RADIOLOGY
- Qualitative and quantitative mass spectrometry imaging of drugs and metabolites in tissue at therapeutic levels
- (2013) Na Sun et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Gastrointestinal stromal tumour
- (2013) Heikki Joensuu et al. LANCET
- Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging
- (2013) Xiaohui Liu et al. Scientific Reports
- Quantitative MALDI Tandem Mass Spectrometric Imaging of Cocaine from Brain Tissue with a Deuterated Internal Standard
- (2012) David A. Pirman et al. ANALYTICAL CHEMISTRY
- MALDIquant: a versatile R package for the analysis of mass spectrometry data
- (2012) S. Gibb et al. BIOINFORMATICS
- Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor
- (2012) Gregory Hamm et al. Journal of Proteomics
- imzML — A common data format for the flexible exchange and processing of mass spectrometry imaging data
- (2012) Thorsten Schramm et al. Journal of Proteomics
- Histopathology of gastrointestinal stromal tumor
- (2011) Markku Miettinen et al. JOURNAL OF SURGICAL ONCOLOGY
- A quantitation method for mass spectrometry imaging
- (2011) Stormy L. Koeniger et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): An emerging role for drug blood level testing?
- (2010) Margaret von Mehren et al. CANCER TREATMENT REVIEWS
- An evaluation of R2 as an inadequate measure for nonlinear models in pharmacological and biochemical research: a Monte Carlo approach
- (2010) Andrej-Nikolai Spiess et al. BMC Pharmacology & Toxicology
- Tumor heterogeneity: Causes and consequences
- (2009) Andriy Marusyk et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Imaging mass spectrometry: Hype or hope?
- (2009) Ron M. A. Heeren et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- MALDI-FTICR Imaging Mass Spectrometry of Drugs and Metabolites in Tissue
- (2008) Dale S. Cornett et al. ANALYTICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation